We are live on
!
Find out more
IB
Intrust Bank Portfolio holdings
AUM
$1.35B
Turnover
12.1%
1-Year Est. Return
37.16%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+37.16%
3 Year Est. Return
+102.36%
5 Year Est. Return
+128.73%
10 Year Est. Return
+460.32%
AUM
$692M
AUM Growth
-$98.5M
(-12%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
410
New
29
Increased
158
Reduced
183
Closed
27
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$23M |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$9.89M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.22M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$3.96M |
| 5 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$1.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.82M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$4.6M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.18M |
| 4 |
Apple
AAPL
|
+$1.97M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.54% |
| 2 | Technology | 12.77% |
| 3 | Healthcare | 10.62% |
| 4 | Financials | 7.83% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Chevron
CVX
$430B
| $4.46M | 0.65% |
30,839
-1,147
| -4% | -$190K |
2013 Q2
36 quarters
|
|
27
Eli Lilly
LLY
$1.12T
| $4.39M | 0.63% |
13,526
+158
| +1% | +$47.4K |
2013 Q2
36 quarters
|
|
28
Johnson & Johnson
JNJ
$610B
| $4.38M | 0.63% |
24,686
+661
| +3% | +$118K |
2013 Q2
36 quarters
|
|
29
Visa
V
$750B
| $4.3M | 0.62% |
21,826
+356
| +2% | +$73.6K |
2013 Q2
36 quarters
|
|
30
Berkshire Hathaway Class A
BRK.A
$1.13T
| $4.09M | 0.59% |
10
| – | – |
2013 Q2
36 quarters
|
|
31
ExxonMobil
XOM
$718B
| $3.9M | 0.56% |
45,568
+6,377
| +16% | +$575K |
2013 Q2
36 quarters
|
|
32
NextEra Energy
NEE
$165B
| $3.89M | 0.56% |
50,271
-1,889
| -4% | -$144K |
2013 Q2
36 quarters
|
|
33
Pfizer
PFE
$168B
| $3.69M | 0.53% |
70,473
-590
| -0.8% | -$30.1K |
2013 Q2
36 quarters
|
|
34
AbbVie
ABBV
$501B
| $3.61M | 0.52% |
23,541
-1,848
| -7% | -$282K |
2013 Q2
36 quarters
|
|
35
Thermo Fisher Scientific
TMO
$258B
| $3.6M | 0.52% |
6,620
-307
| -4% | -$169K |
2013 Q2
36 quarters
|
|
36
NVIDIA
NVDA
$5.25T
| $3.27M | 0.47% |
215,760
-16,810
| -7% | -$317K |
2017 Q3
19 quarters
|
|
37
Home Depot
HD
$308B
| $3.19M | 0.46% |
11,611
-105
| -0.9% | -$31K |
2013 Q2
36 quarters
|
|
38
Union Pacific
UNP
$172B
| $3.18M | 0.46% |
14,925
-364
| -2% | -$82.8K |
2013 Q2
36 quarters
|
|
39
Tesla
TSLA
$1.43T
| $3.18M | 0.46% |
14,154
-2,067
| -13% | -$564K |
2020 Q3
7 quarters
|
|
40
Broadridge
BR
$19.7B
| $3.01M | 0.44% |
21,131
-2,038
| -9% | -$296K |
2013 Q2
36 quarters
|
|
41
Verizon
VZ
$184B
| $2.9M | 0.42% |
57,147
+7,612
| +15% | +$385K |
2013 Q2
36 quarters
|
|
42
Merck
MRK
$358B
| $2.89M | 0.42% |
31,719
+2,336
| +8% | +$207K |
2013 Q2
36 quarters
|
|
43
Prologis
PLD
$121B
| $2.87M | 0.41% |
24,382
-560
| -2% | -$77.4K |
2015 Q3
27 quarters
|
|
44
Abbott
ABT
$181B
| $2.8M | 0.4% |
25,778
+533
| +2% | +$60.5K |
2013 Q2
36 quarters
|
|
45
Bristol-Myers Squibb
BMY
$124B
| $2.65M | 0.38% |
34,377
+3,092
| +10% | +$235K |
2013 Q2
36 quarters
|
|
46
Meta Platforms (Facebook)
META
$1.88T
| $2.56M | 0.37% |
15,861
-2,043
| -11% | -$394K |
2013 Q3
35 quarters
|
|
47
Procter & Gamble
PG
$365B
| $2.52M | 0.36% |
17,552
-187
| -1% | -$28.1K |
2013 Q2
36 quarters
|
|
48
Broadcom
AVGO
$1.64T
| $2.51M | 0.36% |
51,620
-3,430
| -6% | -$193K |
2015 Q3
27 quarters
|
|
49
McDonald's
MCD
$172B
| $2.46M | 0.36% |
9,986
+546
| +6% | +$134K |
2013 Q2
36 quarters
|
|
50
AT&T
T
$161B
| $2.37M | 0.34% |
112,990
-8,180
| -7% | -$163K |
2013 Q2
36 quarters
|
|
Similar funds
CC
HVCM
RI
RCYC
KB
NC
PP
OPFM
Intrust Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Intrust Bank held 410 positions worth $692M, down 12% from $790M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Intrust Bank deployed $27.7M of net new capital in Q2 2022, opening 29 new positions and adding to 158 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.82M trimmed.
- Intrust Bank's largest Q2 2022 buy was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
- Intrust Bank added most to Vanguard FTSE Developed Markets ETF in Q2 2022, an estimated $5.22M increase.
- Intrust Bank's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.82M.
- Intrust Bank fully exited Akamai in Q2 2022, selling an estimated $585K.
- Intrust Bank's ten largest holdings make up 40% of its $692M portfolio in Q2 2022.
- Intrust Bank opened 29 new positions and closed 27 in Q2 2022.
- Intrust Bank's portfolio value fell 12% quarter-over-quarter to $692M.
Based on Intrust Bank's 13F filing for Q2 2022, filed 16 Aug 2022.